synapep bpc-157 (10mg) bpc 157 orals Synapep BPC

Active pharmaceutical ingredients are sourced from FDA-registered suppliers with verified Certificates of Analysis

What sets it apart from Ipamorelin: Sermorelin was FDA-approved under the brand name Geref first as a diagnostic agent in 1990, then for GH deficiency in children in 1997 (Federal Register, PubMed)

The delay in implementation was to ensure stakeholders had enough time to learn and adapt to this change, especially as it pertained to the education of athletes, their entourage, and medical personnel

TransformPeptides preserves unreconstituted lyophilized peptides in a freezer (-20C) for long-term stability